Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESOV: Triptorelin for Ovarian Reserve in Young Cancer Patients
NCT02856048Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2016
- Primary completion
- Feb 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in primary ovarian insufficiency (POI), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
triptorelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT02856048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856048.